Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Review Erowid at GreatNonprofits.org
Help us be a 2021 "Top Rated Nonprofit", and spread accurate info
about psychoactive drugs, health, culture, & policies.
("Share Your Story" link. Needs quick account creation but doesn't verify contact info)
PMA Journal Articles & Abstracts


General
Fatalities
Pharmacology
Psychopharmacology
PMMA

GENERAL

Application of solid-phase microextraction to the profiling of an illicit drug: manufacturing impurities in illicit 4-methoxyamphetamine,
Coumbaros JC. Kirkbride KP. Klass G
Journal of Forensic Sciences 44(6):1237-42, 1999

Investigation of the Illicit Manufacture of 4-MA and 4-MTA Using Solid Phase Microextraction,
P. Kirkbride; D. Ward; G. Klass
Paper presented at The 15th International Symposium on the Forensic Sciences 2000
[Abstract]



FATALITIES

The agony of "ecstasy": How can we avoid more "ecstasy"-related deaths?,
J.M. White; F. Bochner; R.J. Irvine
Medical Journal of Australia Vol 116, 1997, 117
[Text]

Amphetamine derivative fatalities in South Australia: Is "ecstasy" the culprit?,
R.W. Byard; J. Gilbert; R. James; R.J. Lokan
American Journal of Forensic Medicine and Pathology Vol 19 (No. 3) 1998; 261-265
[Index]

Amphetamine derivative related deaths. (in Spain),
Lora-Tamayo C, Tena T, Rodriguez A
Forensic Science Int 85(2):149-57, 1997.

Another PMA-related fatality in Adelaide [letter],
Byard RW, James RA, Gilbert JD, Felgate PD
Medical Journal of Australia Vol 170(3) 1999; 139-140
[Text]

Hyperpyrexia associated with fatal paramethoxyamphetamine (PMA) abuse,
James RA. Dinan A
Medicine, Science & the Law 38(1):83-5, 1998

PMA deaths in Ontario,
Cimbura G
Cannadian Medical Association Journal 110, 1263-1267, 1974

Recent Paramethoxyamphetamine Deaths (case report),
Felgate HE, Felgate PD, James RA, Sims DN, Vozzo DC
Journal of Analytical Toxicology 1998; 22(2):169-72
[Index]



PHARMACOLOGY

Comparison of Cardiovascular, Hyperthermic and Toxic Effects of Para-Methoxyamphetamine (PMA) and 3,4-Methylenedioxyamphetamine (MDA),
Nichols DE, Ilhan M, Long JP
Arch Int de Pharmacodynamie et de Therapie 1975; 214(1):133-140
[Index]

Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat,
Daws EC, Irvine RJ, Callaghan PD, Toop NP, White JM, Bochner F
Prog Neuropsychopharmacol Biol Psychiatry 2000; 24(6):955-77
[Index]

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes,
Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW
J Med Chem 1982; 25(5):530-5
[Index]

Effects of Para-Methoxyamphetamine (PMA) on the Cardiovascular System of the Dog,
H.C. Cheng; J.P. Long; D.E. Nichols; C.F. Barfknecht
Arch. Int Pharmocodyn Therap Vol 212, 1974; 83-88

Excretion of p-methoxyamphetamine administered to humans,
Schweitzer JW, Friedhoff AJ, Angrist BM, Gershon S
Nature 229(5280):133-4, 1971

Interactions of amphetamine analogs with human liver CYP2D6,
Wu D, Otton SV, Inaba T, Kalow W, Sellers EM
Biochem Pharmacol 1997; 53(11):1605-12
[Index]

Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine,
Kitchen I, Tremblay J, Andre J, Dring LG, Idle JR, Smith RL, Williams RT
Xenobiotica 9(7):397-404, 1979

Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives,
Bach MV. Coutts RT. Baker GB
Xenobiotica 29(7):719-32, 1999

p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo,
Green AL, El Hait MA
Journal of Pharmacy & Pharmacology Vol 32(4):262-6, 1980

The protective effects of methysergide, 6-hydroxydopamine and other agents on the toxicity of amphetamine, phentermine, MDA, PMA, and STP in mice,
Lopatka JE, Brewerton CN, Brooks DS, Cook DA, Paton DM
Res Commun Chem Pathol Pharmacol 1976; Vol 14(4):677-87
[Index]

Structural elucidation of an uncommon phenylethylamine analogue in urine responsible for discordant amphetamine immunoassay results. (N-ethyl-4-methoxyamphetamine),
Marson C, Schneider S, Meys F, Wennig R
Journal of Analytical Toxicology Vol 24(1):17-21, 2000

3-O-methyl-alpha-methyldopamine, a urinary metabolite of p-methoxyamphetamine in dog and monkey,
Hubbard JW, Bailey K, Midha KK, Cooper JK
Drug Metabolism & Disposition Vol 9(3):250-4, 1981



PSYCHOPHARMACOLOGY

Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine,
Hegadoren KM, Martin-Iverson MT, Baker GB
Psychopharmacology (Berl), 1995; 118(3):295-304
[Index]

Investigation of p-methoxyamphetamine excretion in amphetamine induced psychosis,
Angrist BM. Schweitzer JW. Friedhoff AJ. Gershon S
Nature, 225(233):651-2, 1970



PMMA

Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA),
Steele TD, Katz JL, Ricaurte GA
Brain Res, 1992; 589(2):349-52
[Index]

Initial characterization of PMMA as a discriminative stimulus,
Glennon RA, Young R, Dukat M, Cheng Y
Pharmacol Biochem Behav, 1997; 57(1-2):151-8
[Index]